A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries
Medical abortion pills may be obtained outside of the formal health system and in this case the package insert may be the only piece of information available to end-users. It is therefore imperative that these package inserts contain current, evidence-based information. Our review of medical abortion package inserts collected in LIMCs revealed a wide variety of information provided. The outdated clinical information suggests a lack of adequate revision of these documents as evidence changes.